← FDA DRUG APPROVALS

FDA ANDA · ANDA075697

BUTORPHANOL TARTRATE

Sponsor: BAXTER HLTHCARE CORP

APPLICATION
ANDA075697
TYPE
ANDA
ORIGINAL APPROVAL
2001-10-23
LATEST ACTION
2019-10-11
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

BUTORPHANOL TARTRATEDiscontinued
BUTORPHANOL TARTRATE 2MG/ML · INJECTABLE · INJECTION

Approval history

2019-10-11Labeling · Supplement 15 · standardAP
2016-12-16Labeling · Supplement 14 · standardAP
2016-12-16Labeling · Supplement 13 · standardAP
2008-06-12Manufacturing (CMC) · Supplement 12AP
2001-10-23OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →